Detection of benign prostatic hyperplasia in general practice: A survey in 18,540 men;Dépistage de l'hypertrophie bénigne de la prostate clinique en médecine générale: Enquête sur 18.540 hommes

Progres en Urologie

Volumn 13, Issue 3, 2003, Pages 416-424

  Flam, Thierry ^a   Montauban, Vincent ^b  

^a Hôpital Cochin ^*  (France)

^b Yamanouchi Pharma   (France)

Author keywords

Benign prostatic hyperplasia; Diagnosis; Epidemiology; Prevalence; Screening

Indexed keywords

ADULT; AGED; CONSULTATION; CONTROLLED STUDY; DEMOGRAPHY; GENERAL PRACTITIONER; HUMAN; MALE; MASS SCREENING; MEDICAL DECISION MAKING; PATIENT REFERRAL; PATIENT SATISFACTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PROSTATE HYPERTROPHY; REVIEW; SELF REPORT; STATISTICAL ANALYSIS; SYMPTOM; ARTICLE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; GENERAL PRACTICE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA;

EID: 0642275360     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. BARTSCH G., McCONNELL J.D., MAHLER C., CALAIS DA SILVA F., KLOCKER H., RICHARD F., DI SILVERIO F. : Endocrine Treatment of Benign Prostatic Hyperplasia. In : 5th International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 25-28, 2000. C. Chatelain, L. Denis, K.T. Foo, S. Khoury, J. Mc Connell eds., Plymbridge distributors Ltd, Plymouth, UK, 2000 ; 423-458.
2. BERGES R.R., PIENTKA L., HOFNER K., SENGE T., JONAS U. : Male lower urinary tract symptoms and related health care seeking in Germany. Eur. Urol., 2001 ; 39 : 682-687.
3. BERRY S.J., COFFEY D.S., WALSH P.C., EWING L.L. : The development of human benign prostatic hyperplasia with age. J. Urol., 1984 ; 132 : 474-479.
4. CALLUM M.G., WELCH-DYER M., LIBERTINO J.A., CAMARGO C.A., INUI T. : The influence of physician age and gender on PSA screening. J. Urol., 2000 ; 163 (part 2), A1251.
5. CHAPPLE C.R., WYNDAELE J.J., NORDLING J., BOEMINGHAUS F., YPMA A., ABRAMS P. : Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. Eur. Urol., 1996 ; 29 : 155-167.
6. CHUTE C.G., PANSER L.A., GIRMAN C.J., OESTERLING J.E., GUESS H.A., JACOBSEN S.J., LIEBER M.M. : The prevalence of prostatism : a population-based survey of urinary symptoms. J. Urol., 1993 ; 150 : 85-88.
7. DREIKORN K., BORKOWSKI A., BUCK C., BRAECKMAN J., CHOPIN D., DENIS L., FERRARI P., HABIB F.K., PERRIN P., LOWE F. : Other Medical Therapies. In : 5th International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 25-28, 2000. C. Chatelain, L. Denis, K.T. Foo, S. Khoury, J. Mc Connell eds., Plymbridge distributors Ltd, Plymouth, UK, 2000 ; 479-512.
8. FINASTERIDE STUDY GROUP : Finasteride (MK-906) in the treatment of benign protatic hyperplasia. Prostate, 1993 ; 22 : 291-299.
9. GARRAWAY W.M., ALEXANDER F.E. : Prostate disease : epidemiology, natural history and demographic shifts. Br. J. Urol., 1997 ; 79 : 3-8.
10. GARRAWAY W.M., COLLINS G.N., LEE R.J. : High prevalence of benign prostatic hypertrophy in the community. Lancet, 1991 ; 338 : 469-471.
11. GARRAWAY W.M., RUSSEL E.B.A.W., LEE R.J., COLLINS G.B., MC KELVIE G.B., HEHIR M., ROGERS A.C.N., SIMPSON R.J. : Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br. J. Gen. Pract., 1993 ; 43 : 318-321.
12. GIRMAN C.J. : Population-based studies of the epidemiology of benign prostatic hyperplasia. Br. J. Urol., 1998 ; 82 : 34-43.
13. HUNTER D.J., BERRA-UNAMUNO A., MARTIN-GORDO A. : Prevalence of urinary symptoms and other urological conditions in Spanish men 50 Years or older. J. Urol., 1996 ; 155 : 1965-1970.
14. JARDIN A., ANDERSSON K.-E., CHAPPLE C., EL HILALI M., KAWABE K., KIRBY R., MICHEL M., POOL J., WYLLIE M.G. : Alpha1-Adrenoceptor Antagonists in the Treatment of BPH. In: 5th International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 25-28, 2000. C. Chatelain, L. Denis, K.T. Foo, S. Khoury, J. Mc Connell eds., Plymouth, UK, Plymbridge distributors Ltd, 2000 ; 459-478.
15. LEPOR H., WILLIFORD W.O., BARRY M.J., HAAKENSON C., JONES K. : The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. J. Urol., 1998 ; 160 : 1358-1367.
16. LUKACS B. : Management of symptomatic BPH in France : who is treated and how ? Eur. Urol., 1999 ; 36 : 14-20.
17. MANTEL N., HAENSZEL W. : Statistical Aspects of the Analysis of Data from Retrospective Studies of Disease. J. Natl. Cancer Inst., 1959 ; 22 : 719-748.
18. NORMAN R.W., NICKEL J.C., FISH D., PICKETT S.N. : "Prostate related symptoms" in Canadian men 50 years of age or older: prevalence and relationship among symptoms. Br. J. Urol., 1994 ; 74 : 542-550.
19. OESTERLING J.E. : Benign prostatic hyperplasia : a review of its histogenesis and natural history. Prostate Suppl., 1996 ; 6 : 67-73.
20. RICHARD F., LUCKAS B., JARDIN A., LANSON Y., CHEVRET-MEASON M., GRANGE RJ.C., NAVRATIL H. : Résultats d'une enquête épidé miologique menée chez des hommes âgés de 50 à 80 ans étudiant les troubles mictionnels, qualité de vie et function sexuelle. Prog. Urol., 2001 ; 11 : 250-263.
21. FARLANE G., RICHARD F., BOTTO H., TEILLAC P., BOYLE P. : Results of an epidemiologic survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J. Urol., 1994 ; 151 : 1266-1270.
22. SAGNIER P.P., RICHARD F., BOTTO H., TEILLAC P., DREYFUS J.P., BOYLE P. : Adaptation et validation en langue francaise du score international des symptomes de l'hypertrophie bénigne de la prostate. Prog. Urol. 1994 ; 4 : 532-538.
23. SCHULMAN C. : Hypertrophie bénigne de la prostate : Quel traitement ? Pour qui ? Rev. Med. Brux., 1999 ; 20 : A212-8.
24. VELA-NAVARRETE R., ALFARO V., BADIELLA L.L., FERNANDEZ-HERNANDO N. : Age-stratified analysis of I-PSS and Qol values in Spanish patients with symptoms potentially related to BPH. Eur. Urol., 2000 ; 38 : 199-207.